Leptospirosis, vaccination, zoonosis, global prevalence, traveler vaccination, tropical countries, waterborne diseases, SPIROLEPT vaccine, Leptospira interrogans, Icterohemorrhagiae, Copenhageni, disease prevention, epidemiology, climate change, water sports, aquatic leisure activities, high-risk professions, mandatory vaccination, reportable disease, France, metropolitan France, vaccine promotion, doctor prescriptions, public health, disease transmission, symptomatology, diagnosis, disease severity, mortality rate, seasonal disease, epidemiological data, vaccine efficacy, vaccine cost, reimbursement, quality information, health interests, sensitization of doctors, Leptospira icterohaemorrhagiae, inactivated vaccine, serogroups, tropical regions, stagnant water, at-risk activities, Cerfa 16292*01 form, mandatory declaration, epidemiology tracking, transmission risks, disease incidence, global health, public awareness, health education, preventive measures, vaccine recommendations, high-risk populations, travel health, occupational health, water contamination, animal urine, human transmission, disease outbreaks, epidemiological surveillance, health policy, vaccination strategy, disease control, global health issues, tropical medicine, infectious diseases, bacterial infections, vaccine development, health promotion, disease management, epidemiological research, public health policy, health risks, disease prevention measures
"Protect yourself from Leptospirosis, a potentially deadly zoonotic disease prevalent globally, especially in tropical regions. With climate change increasing risk areas and over 1 million severe cases diagnosed annually worldwide, vaccination is crucial for high-risk professionals and travelers. The SPIROLEPT vaccine offers 99% protection against severe forms caused by serogroups Icterohemorrhagiae and Copenhageni. Recommended for those exposed to contaminated water, it's essential for preventing kidney failure and death. Stay informed, get vaccinated, and reduce your risk."
[...] Transmission of Leptospirosis B. Symptomatology and Diagnosis of Leptospirosis Part Medical Information A. Treatment of Leptospirosis B. Prevention of Leptospirosis Cases in France: Recommended Vaccination Categories for Population Part Promotion of the Leptospirosis Vaccine A. Cases of Mandatory Vaccination B. Epidemiological Data C. Marketing Plan 1. Balance: Evolution of the number of travelers, climate changes, severity of the disease, and number of deaths per year 2. The vaccine: Retrospective on data, objectives achieved, highlighting results on recommended vaccination populations 3. [...]
[...] In France, since August leptospirosis is a reportable disease, which allows for tracking epidemiology and limiting the risks of transmission (cf. annex 1). Human transmission of leptospirosis occurs mainly through skin contact with bacteria present in fresh water and muddy soils contaminated by the urine of infected animals on damaged skin, which explains the seasonality of epidemics (due to good weather, water activities are more frequent) but also the higher incidence in tropical areas due to local climatic and living conditions. [...]
[...] In France, vaccination is recommended for high-risk professionals, as well as for travelers with a high risk of exposure. The vaccine provides protection in 99% of cases against severe and deadly forms of leptospirosis caused by serogroups Icterohemorrhagiae and Copenhageni (the most dangerous for humans and responsible for approximately 30% of leptospirosis cases). Problems Leptospirosis is a little-known disease but tends to progress in metropolitan areas. This progression can be explained by climate change, which can promote areas of stagnant water, but also by the multiplication of 'at-risk' activities (water sports, aquatic leisure activities). [...]
APA Style reference
For your bibliographyOnline reading
with our online readerContent validated
by our reading committee